Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-196
Closed -$4.9K 437
2025
Q4
$4.9K Sell
196
-1,923
-91% -$48.5K ﹤0.01% 273
2025
Q3
$55.1K Buy
+2,119
New +$52.3K 0.04% 159
2025
Q2
Sell
-2,282
Closed -$57.8K 534
2025
Q1
$57.8K Buy
2,282
+62
+3% +$1.62K 0.05% 135
2024
Q4
$58.8K Buy
+2,220
New +$60.2K 0.06% 127

Other funds holding PFE

Winnow Wealth's PFE Position: Q1 2026 in Review

Winnow Wealth sold out of Pfizer (PFE) in Q1 2026, closing a stake of 196 shares — an estimated $4.9K sold.

Winnow Wealth first reported a position in PFE in Q4 2024 and held it in 4 quarters. The position peaked at $58.8K in Q4 2024. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Winnow Wealth reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Winnow Wealth sold 196 Pfizer shares in Q1 2026, an estimated $4.9K.
  • Winnow Wealth first reported a position in Pfizer in Q4 2024 and held it in 4 quarters.
  • Winnow Wealth's Pfizer position peaked at $58.8K in Q4 2024.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Winnow Wealth's 13F filing for Q1 2026, filed 19 May 2026.